Xencor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
CEOBassil I. Dahiyat
CEOBassil I. Dahiyat
Employees250
Employees250
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1997
Founded1997
Employees250
Employees250
XNCR Key Statistics
Market cap783.74M
Market cap783.74M
Price-Earnings ratio-3.03
Price-Earnings ratio-3.03
Dividend yield—
Dividend yield—
Average volume783.87K
Average volume783.87K
High today$11.24
High today$11.24
Low today$10.29
Low today$10.29
Open price$10.44
Open price$10.44
Volume777.58K
Volume777.58K
52 Week high$27.24
52 Week high$27.24
52 Week low$7.16
52 Week low$7.16
XNCR News
TipRanks 1d
Xencor reports ‘positive’ interim results from XmAb942 volunteer studyXencor (XNCR) announced positive interim results from its first-in-human study of XmAb942, a high-potency, extended half-life, investigational anti-TL1A antibod...
Simply Wall St 5d
Is Xencor A Risky Investment?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonym...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
0%
Sell
8.3%
People also own
Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.